Keros Therapeutics, Inc.
CRYSTAL FORMS OF AN ALK2 INHIBITOR

Last updated:

Abstract:

The invention relates to crystalline forms of an ALK2 inhibitor, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to pharmaceutical uses of the crystalline forms.

Status:
Application
Type:

Utility

Filling date:

23 Apr 2021

Issue date:

5 Aug 2021